IO Biotech   Report issue

For profit Phase 2 Phase 3
Founded: Copenhagen Denmark (2014)

Organization Overview

First Clinical Trial
2018
NCT03562871
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

IO Biotech